Speaker

Home•Speakers•Alexandra Alvergne

Alexandra Alvergne

CNRS Research Fellow (Institute for Evolutionary Sciences, Montpellier University)

Alexandra Alvergne is a member of CNRS: The French National Centre for Scientific Research and was previously Associate Professor in Biocultural Anthropology and a Fellow of Harris Manchester College at Oxford University.

Her research focuses on understanding the relationship between reproduction and female health, including working on contraceptive dynamics, infection and menstrual health, diversity in age at menopause and the impact of reproduction on ageing.

She seeks to answer questions such as why women discontinue modern contraception whilst in need of contraceptives, what the impact of infection on menstrual health is, how to better understand diversity in age at menopause and what the impact of is reproduction is on ageing.

AllSessions

Day 2
May 27, 2021
6:45 pm

RoundTable: Pain and Symptom Management

From as far back as Ancient Egypt medicine has been rife with recorded descriptions of gynecological conditions and the physiological pain they cause. In fact, ancient Egypt has the first recorded use of the term ‘wandering uterus’ – but it was not until ancient Greece and then Rome after it that the term ‘hysteria’ was coined, often used to dismiss a vast array of symptoms exhibited by women, attributed to their physiological abnormalities. And yet a disturbing lack of innovation to help track, manage and perhaps even cure the pain caused by gynecological conditions has been historically achieved – until today. In this panel we explore the innovative technologies being put forth to treat gynecological conditions: from pre-empting menopausal symptoms, to treating endometriosis with cannaboids to the all importance of tracking the symptoms to help manage them......Alexandra Alvergne; an Oxford Fellow and CNRS researcher whose research focuses on understanding the relationship between reproduction and female health, including working on contraceptive dynamics, infection and menstrual health, diversity in age at menopause and the impact of reproduction on ageing......... Dr, Sari Prutchi Sagiv, VP of R&D at Gynica : a medical company researching and developing cannabinoid solutions to target gynaecological symptoms and diseases......... Cécile Real, Co-Founder + CEO of EndoDiag: company developing new endometriosis diagnostic solutions for healthcare professionals. These solutions are intended to contribute to a better endometriosis diagnosis, a more personalized patient management, more efficient treatment options and fertility strategy.......... Chantelle Bell & Anya Roy, Co-Founders of Syrona Health : a startup that tracks endo and health symptoms, and allows users to access a community of patients with similar symptoms as well as providing doctor approved insights.
Chantelle BellCécile RealAlexandra AlvergneDr. Sari Prutchi SagivAnya Roy
27 May
Time:  6:45 pm - 8:15 pm
Location:  From as far back as Ancient Egypt medicine has been rife with recorded descriptions of gynecological conditions and the physiological pain they cause. In fact, ancient Egypt has the first recorded use of the term ‘wandering uterus’ – but it was not until ancient Greece and then Rome after it that the term ‘hysteria’ was coined, often used to dismiss a vast array of symptoms exhibited by women, attributed to their physiological abnormalities. And yet a disturbing lack of innovation to help track, manage and perhaps even cure the pain caused by gynecological conditions has been historically achieved – until today. In this panel we explore the innovative technologies being put forth to treat gynecological conditions: from pre-empting menopausal symptoms, to treating endometriosis with cannaboids to the all importance of tracking the symptoms to help manage them......Alexandra Alvergne; an Oxford Fellow and CNRS researcher whose research focuses on understanding the relationship between reproduction and female health, including working on contraceptive dynamics, infection and menstrual health, diversity in age at menopause and the impact of reproduction on ageing......... Dr, Sari Prutchi Sagiv, VP of R&D at Gynica : a medical company researching and developing cannabinoid solutions to target gynaecological symptoms and diseases......... Cécile Real, Co-Founder + CEO of EndoDiag: company developing new endometriosis diagnostic solutions for healthcare professionals. These solutions are intended to contribute to a better endometriosis diagnosis, a more personalized patient management, more efficient treatment options and fertility strategy.......... Chantelle Bell & Anya Roy, Co-Founders of Syrona Health : a startup that tracks endo and health symptoms, and allows users to access a community of patients with similar symptoms as well as providing doctor approved insights.
Speaker:  Chantelle BellCécile RealAlexandra AlvergneDr. Sari Prutchi SagivAnya Roy